pembrolizumab
neoimmunetech,merck
['pembro', 'neoimmune']
we're excited to announce that data from our poster being presented at #esmo22 demonstrates that the combination of nt-i7 and pembrolizumab has promising clinical efficacy in very cold and immunosuppressive indications. read more 
NIT is a clinical-stage T cell-focused biotech company, dedicated to expand the horizon of Immuno-Oncology and infectious diseases